Literature DB >> 23035818

Fluoroquinolone prophylaxis: worth the cost?

Gabrielle M Haeusler1, Monica A Slavin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23035818     DOI: 10.3109/10428194.2012.736988

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  6 in total

1.  Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.

Authors: 
Journal:  GMS Hyg Infect Control       Date:  2022-04-13

Review 2.  The prevention and management of infections due to multidrug resistant organisms in haematology patients.

Authors:  Jason A Trubiano; Leon J Worth; Karin A Thursky; Monica A Slavin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

3.  The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients.

Authors:  Jason A Trubiano; Vivian K Leung; Man Y Chu; Leon J Worth; Monica A Slavin; Karin A Thursky
Journal:  Antimicrob Resist Infect Control       Date:  2015-06-01       Impact factor: 4.887

4.  Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States.

Authors:  Jason N Barreto; Samuel L Aitken; Elizabeth M Krantz; Jerod L Nagel; Sanjeet S Dadwal; Susan K Seo; Catherine Liu
Journal:  Open Forum Infect Dis       Date:  2022-02-04       Impact factor: 4.423

5.  Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.

Authors:  Joshua Wolf; Li Tang; Patricia M Flynn; Ching-Hon Pui; Aditya H Gaur; Yilun Sun; Hiroto Inaba; Tracy Stewart; Randall T Hayden; Hana Hakim; Sima Jeha
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

6. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.